12:00 AM
 | 
Sep 15, 2008
 |  BC Week In Review  |  Company News  |  Deals

SBI Holdings Inc., AstraZeneca deal

SBI Holdings' SBI Biotech Co. Ltd. subsidiary granted AstraZeneca's MedImmune Inc. subsidiary exclusive, worldwide rights to a preclinical murine antibody against leukocyte immunoglobulin-like...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >